BioSpace News Archive

Osel Inc., announced today that City of Hope, a world-renowned independent cancer and diabetes research and treatment center, presented data from a Phase 1b trial showing that an LBP, CBM588 (Clostridium butyricum MIYAIRI 588® strain), plus nivolumab/ipilimumab

exocad GmbH, an Align Technology, Inc. company and one of the leading dental CAD/CAM software manufacturers, announced the release of more than 35 educational webinars to showcase highlights and demonstrate new features of exocad’s DentalCAD 3.0 Galway and other products under the new educational umbrella Creator Center.

Findings show key mutations and evolution of U.K. SARS-CoV-2 compared to earlier lineages account for upregulation of innate immune antagonists, which hamper immune response and allow for increased viral replication and duration of infection

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced a combined long-term overall survival (OS) analysis from three clinical studies of tabelecleucel

QPharma, a leader in Medical, Commercial and Compliance services for the life sciences industry, is proud to announce establishment of Neolytica, a subsidiary that will take healthcare analytics to an entirely different level.

AbbVie (NYSE: ABBV) today announced new data from the Phase 2 CAPTIVATE (PCYC-1142) study investigating IMBRUVICA® (ibrutinib) in combination with VENCLEXTA®/VENCLYXTO®

Synaptogenix, Inc. (Nasdaq: SNPX), an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today issued a statement following the announced FDA approval of Biogen’s new Alzheimer’s treatment Aducanumab.

According to The Insight Partners market research study titled ‘Autotransfusion Device Market to 2027 –COVID-19 Impact and Global Analysis – by Type, Application, End User, and Geography.

The report highlights trends prevailing in the global GMP cytokines market and factors governing the market growth.

The report highlights the trends prevailing in the market, and drivers and deterrents pertaining to the market growth.